Skip to main content
Thor Medical ASA logo

Thor Medical ASA — Investor Relations & Filings

Ticker · NANOV ISIN · NO0010597883 LEI · 5967007LIEEXZXG6DK30 OL Manufacturing
Open in API
Filings indexed 109 across all filing types
Latest filing 2026-06-12 Director's Dealing
Country NO Norway
Listing OL NANOV

About Thor Medical ASA

https://www.thormedical.com/

Thor Medical ASA is a producer and supplier of alpha-particle emitters for cancer therapy. The company specializes in manufacturing isotopes, such as Thorium-228, by separating decay products from naturally occurring Thorium-232. This is achieved through a proprietary production technology that offers high efficiency, cost-competitiveness, and superior environmental friendliness. The company provides these critical alpha-emitters to partners developing next-generation targeted alpha therapies for precision oncology.

Recent filings

Filing Released Lang Actions
TRMED - Executive Management Share Purchase - Attachment: 20260612 - TRMED - PDMR notification MAR_PDF.pdf
Director's Dealing Classification · 100% confidence The document is a notification of transactions pursuant to the Market Abuse Regulation Article 19. It reports personal share transactions made by a person discharging managerial responsibilities, specifically the purchase of shares. This type of document matches the definition of 'Director's Dealing' (DIRS), which involves reporting personal share transactions by company directors and executives (insider trades). The content is focused solely on such transactions and does not contain broader financial report information or other types of filings.
2026-06-12 English
TRMED - Executive Management Share Purchase - Attachment: Download announcement as PDF.pdf
Director's Dealing Classification · 100% confidence The document is a mandatory notification of trade by a primary insider (Mathias Nilsen Reierth) purchasing shares in the company. It references Article 19 of the Market Abuse Regulation, which pertains to insider transactions. The content focuses on disclosing a director's/insider's personal share transaction. The document length is short and is an announcement rather than a comprehensive report. This matches the definition of 'Director's Dealing' filings.
2026-06-12 English
TRMED - Executive Management Share Purchase
Director's Dealing Classification · 100% confidence The document is a notification of a personal share transaction by a primary insider, Mathias Nilsen Reierth, who purchased shares in the company. It references compliance with the Market Abuse Regulation Article 19, indicating a regulatory filing of insider trading. There is no financial data or report content, just a mandatory trade disclosure with attached notifications. Therefore, this fits the category for Director's Dealing reports.
2026-06-12 English
Thor Medical Enters Partnership Agreement with Minerva Imaging to Support Availability of Lead-212 in Europe - Attachment: Download announcement as PDF.pdf
Regulatory Filings Classification · 75% confidence The document is a corporate press release announcing a strategic partnership and supply agreement between Thor Medical and Minerva Imaging. It does not contain financial statements, regulatory form references, management changes, capital transactions, or other specific report content. It is a general corporate announcement, thus best classified under the fallback category for miscellaneous regulatory announcements.
2026-05-29 English
Thor Medical Enters Partnership Agreement with Minerva Imaging to Support Availability of Lead-212 in Europe
Regulatory Filings Classification · 85% confidence The document is a corporate press release announcing a partnership and supply agreement between Thor Medical ASA and Minerva Imaging. It contains no financial results, no shareholder votes, no regulatory form references, no proxy materials, and no management changes. It is not a formal financial report or earnings release, but rather a general business announcement. There is no specific form or detailed financial data, so it falls into the fallback category for general regulatory announcements.
2026-05-29 English
Thor Medical Enters Partnership with Eckert & Ziegler to Enable Access of Lead-212 for the Pharmaceutical Industry - Attachment: Download announcement as PDF.pdf
Regulatory Filings Classification · 35% confidence The document is a non-regulatory press release announcing a collaboration agreement between Thor Medical ASA and Eckert & Ziegler. It contains no financial statements, management change notices, earnings data, or regulatory disclosures, and does not fit any specific filing category such as M&A, capital update, or dividend notice. As such, it falls into the miscellaneous/general announcements category, which in our taxonomy corresponds to Regulatory Filings (RNS) as the fallback classification.
2026-05-28 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.